Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 6:20 AM ET

Diversified Consumer Services

Company Overview of Universite De Montreal, L'

Company Overview

PO Box 6128

Station Centre-ville

Montréal, QC H3C 3J7




Key Executives for Universite De Montreal, L'

Vice-Rector of Development and Alumni Relations
Compensation as of Fiscal Year 2015.

Universite De Montreal, L' Key Developments

Universite De Montreal, L' Presents at Milken Institute, Global Conference 2015, Apr-27-2015 03:45 PM

Universite De Montreal, L' Presents at Milken Institute, Global Conference 2015, Apr-27-2015 03:45 PM. Venue: 2025 Ave Of The Stars, Los Angeles, CA 90067, California, United States. Speakers: Yves Joanette, Professor of Cognitive Neurosciences and Aging.

Universite De Montreal, L' Presents at Canadian Hydropower Association Forum 2014, May-27-2014

Universite De Montreal, L' Presents at Canadian Hydropower Association Forum 2014, May-27-2014 . Venue: Fairmont Château Laurier, 1 Rideau Street, Ottawa, Ontario, Canada. Speakers: Daniel Boisclair.

Domain Therapeutics, Universite de Montreal, IRICoR and McHill University Ink New Licensing Pact on G-Protein Coupled Receptor Biosensor Technology

Domain Therapeutics announced the signing of a licensing and partnership agreement on GPCR biosensor technology with Universite de Montreal (UdeM) and its commercialization unit, with the Institute for Research in Immunology and Cancer - Commercialization of Research (IRICoR), as well as with McGill University. The GPCR biosensor technology was developed with the support of a grant from the Quebec Consortium for Drug Discovery (CQDM), whose mission is to fund breakthrough technologies with the financial support of major pharma companies. This project was overseen by a team of researchers from UdeM's Institute for Research in Immunology and Cancer (IRIC) led by Dr. Michel Bouvier. Dr. Bouvier is internationally renowned for his work on GPCRs. The agreement gives Domain Therapeutics co-exclusive access, with AstraZeneca, Merck and Pfizer having access via their participation in the CQDM, to biosensor technology developed by Dr. Bouvier's team. This new approach, which makes it possible to discriminate the functional activation of intracellular signalling pathways associated with GPCRs, is considered a prime technology for accelerating the discovery and development of biased ligands for this class of receptors.

Similar Private Companies By Industry

Company Name Region
Integra Tire and Auto Centers Ltd. Americas
Keycorp Inc. Americas
Stratford Memorials Limited Americas
Airline Training International Ltd. Americas
Academy of Learning Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Universite De Montreal, L, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at